BMI1 is involved in the occurrence and development of many types of cancer through a variety of signaling pathways. BMI1, which is overexpressed in cancer, is often associated with chemo- and radiation resistance and poor prognosis in cancer patients. This article reviews the current understanding of the mechanism of BMI1 in maintaining tumor stemness, promoting metastasis, and inducing chemo- and radiation resistance, aiming at providing updated information supportive of targeting BMI1 in cancer treatment
<p>(A) mRNA (up) and protein (down) expression levels of Bmi1 in selected breast cancer cells; (B) D...
Recent studies suggest that ALDH1 is a putative marker for HNSCC-derived cancer stem cells. However,...
Abstract: Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesi...
Cancer is a highly dynamic disease characterized by dedifferentiation, heterogeneity, and plasticity...
AbstractBmi-1 is a member of the Polycomb repressor complex 1 that mediates gene silencing by regula...
Bmi1 is an integral component of the Polycomb Repressive Complex 1 (PRC1) and is involved in the pat...
Radiotherapy is a widely used treatment for cancer. However, recent studies suggest that ionizing ra...
Background: Bmi1 is an integral component of the Polycomb Repressive Complex 1 (PRC1) and is involve...
BMI1 plays critical roles in maintaining the self-renewal of hematopoietic, neural, intestinal stem ...
Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesis of vario...
Background: The Bmi1 polycomb ring finger oncogene, a transcriptional repressor belonging to the Pol...
For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistance and pa...
Background: The Bmi1 polycomb ring finger oncogene, a transcriptional repressor belonging to the Pol...
BMI1 plays critical roles in maintaining the self-renewal of hematopoietic, neural, intestinal stem ...
<div><p>For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistanc...
<p>(A) mRNA (up) and protein (down) expression levels of Bmi1 in selected breast cancer cells; (B) D...
Recent studies suggest that ALDH1 is a putative marker for HNSCC-derived cancer stem cells. However,...
Abstract: Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesi...
Cancer is a highly dynamic disease characterized by dedifferentiation, heterogeneity, and plasticity...
AbstractBmi-1 is a member of the Polycomb repressor complex 1 that mediates gene silencing by regula...
Bmi1 is an integral component of the Polycomb Repressive Complex 1 (PRC1) and is involved in the pat...
Radiotherapy is a widely used treatment for cancer. However, recent studies suggest that ionizing ra...
Background: Bmi1 is an integral component of the Polycomb Repressive Complex 1 (PRC1) and is involve...
BMI1 plays critical roles in maintaining the self-renewal of hematopoietic, neural, intestinal stem ...
Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesis of vario...
Background: The Bmi1 polycomb ring finger oncogene, a transcriptional repressor belonging to the Pol...
For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistance and pa...
Background: The Bmi1 polycomb ring finger oncogene, a transcriptional repressor belonging to the Pol...
BMI1 plays critical roles in maintaining the self-renewal of hematopoietic, neural, intestinal stem ...
<div><p>For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistanc...
<p>(A) mRNA (up) and protein (down) expression levels of Bmi1 in selected breast cancer cells; (B) D...
Recent studies suggest that ALDH1 is a putative marker for HNSCC-derived cancer stem cells. However,...
Abstract: Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesi...